BioTelemetry Trumps Aevis' Takeover Bid For LifeWatch

Swiss firm LifeWatch has been offered a sweeter acquisition deal from BioTelemetry at a proposed CHF260m. The company was recently subject to a proposed takeover by investment firm Aevis Victoria SA.

More from Cardiology

More from Device Area